Coronavirus Update: UK Calls For COVID-19 Patients To Join Trials
Reflects Global COVID-19 Trial Recruitment Challenge
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
You may also be interested in...
An industry consortium will drive forward new manufacturing processes in parallel with the Oxford group’s COVID-19 vaccine clinical studies; these studies could produce Phase III efficacy results by this autumn.
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.
Companies continue to throw their hats into the ring against the virus, with strategies ranging from ‘off the shelf’ molecules to novel vaccine and anti-viral therapies